The misdiagnosis rate and missed diagnosis rate of its combined test are lower than those of serum TAP test and serum CEA test, indicating that the use of TAP + CEA combined test to detect patients with thyroid nodules of type IV and above can improve the diagnostic efficiency of their thyroid cancer and reduce its missed diagnosis rate and misdiagnosis rate. This evidence concerns the gene CEACAM5 and thyroid nodule.